Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria

Authors :: Elisabetta Di Leo
Angelo Vacca
Luca Cegolon
Eustachio Nettis
Caterina Foti
Nettis, Eustachio
Di Leo, Elisabetta
Foti, Caterina
Cegolon, Luca
Vacca, Angelo
Source :: Journal of the American Academy of Dermatology. 78:1211-1213
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.
Abstract: N/A

Subjects :: Male
Urticaria
Omalizumab
Severity of Illness Index
Cohort Studies
030207 dermatology & venereal diseases
0302 clinical medicine
Retrospective Studie
Recurrence
Monoclonal
media_common
biology
Subcutaneous
Antibodies, Monoclonal
Middle Aged
Prognosis
Treatment Outcome
Retreatment
Female
Drug
Antibody
Adult
Chronic Disease
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Injections, Subcutaneous
Retrospective Studies
Risk Assessment
Risk assessment
Human
Cohort study
medicine.drug
medicine.medical_specialty
Prognosi
media_common.quotation_subject
MEDLINE
Dermatology
Injections, Subcutaneou
Antibodies
Injections
Dose-Response Relationship
03 medical and health sciences
Internal medicine
Severity of illness
medicine
business.industry
Retrospective cohort study
030228 respiratory system
biology.protein
Cohort Studie
business

Full Text Access

Tools